Springer Nature OA
open access
CC BY 4.0
Non-pharmacological treatment of MASLD
Non-pharmacological treatment of metabolic dysfunction-associated steatotic liver disease (MASLD) aims at modifying lifestyle patterns that promote metabolic dysfunction and hepatic fat accumulation. These include unhealthy dietary habits, which are characterised by excess energy intake and a qualit
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Pharmacological treatment of MASH#1148616
- Disease-Modifying Therapies for Metabolic Dysfunction–Associated Steatohepatitis: Health Systems#388565
- A Study to Evaluate DD01 in Overweight/Obese Subjects With MASLD/MASH#1048061
- Study of Metabolic Dysfunction-Associated Steatotic Liver Disease Among Sohag University Employees#1127445
- A computational model of inflammation reveals crosstalk among energy metabolism, oxidative stress, insulin, and cytokines in hepatocytes during early MASLD progression#1079255
Record · ID 1148615
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive